Turkish Medical Translation Services

Yes. We produce Turkish-language dossiers for TITCK drug registration and medical device marketing authorization, following the Agency's specific formatting and terminology requirements.

Yes. We translate clinical trial protocols, investigator brochures, and patient-facing materials for Turkish clinical sites, ensuring compliance with Turkish Ministry of Health ethics committee requirements.

We build client-specific Turkish medical glossaries and translation memories at project start and maintain them throughout the full regulatory dossier lifecycle.

Yes. Turkey's Medicines and Medical Devices Agency (TITCK) requires specific Turkish-language document structures and terminology for drug and device registrations. Our translators apply TITCK-specific terminology conventions for drug classification, dosage terminology, adverse event reporting, and device risk categories. For products following the parallel EU MDR pathway we also apply EU technical file requirements where TITCK accepts mutual recognition.

A standalone Turkish informed consent form of 2,000 to 4,000 words typically delivers in 2 to 3 business days including QA. A full investigator brochure or 50-page TITCK registration module runs 5 to 10 business days. Turkish text typically expands 15 to 20 percent over English source due to agglutinative word formation; factor this into page count estimates. For multi-country studies running Turkish in parallel with other language versions we assign a dedicated project manager to align all timelines.